SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. J Rheumatol 1994; 21: 16205.
  • 2
    Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol 1996; 44 Suppl 23: 1322.
  • 3
    Rasker JJ, Cosh JA. Course and prognosis of early rheumatoid arthritis. Scand J Rheumatol Suppl 1989; 79: 4556.
  • 4
    Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998; 41: 157182.
  • 5
    Kirwan J. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol 1997; 36: 2258.
  • 6
    Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996; 35: 12638.
  • 7
    Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 11524.
  • 8
    Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 130815.
  • 9
    Prevoo ML, van Gestel AM, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis: American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 1996; 35: 11015.
  • 10
    Wolfe F, Hawley DJ. Remission in rheumatoid arthritis. J Rheumatol 1985; 12: 24552.
  • 11
    Harrison BJ, Symmons DP, Brennan P, Barret EM, Silman AJ. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 1996: 35: 1096100.
  • 12
    Eberhardt K, Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after five years. Br J Rheumatol 1998; 37: 13249.
  • 13
    Ten Wolde S, Breedveld FC, Hermans J, Vandenbroucke JP, van de Laar MA, Markusse HM, et al. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 1996; 347: 34752.
  • 14
    Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 15
    Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 7424.
  • 16
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 72940.
  • 17
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393406.
  • 18
    Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984; 3: 3059.
  • 19
    Van der Heijde DM, van't Hof MA, van Riel PL, Theumisse LM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1989; 49: 91620.
  • 20
    Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 120513.
  • 21
    Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FWJ, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 10368.
  • 22
    Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 7208.
  • 23
    Lassere MN, van der Heijde D, Johnson K, Bruynesteyn K, Molenaar E, Boonen A, et al. Robustness and generalizability of smallest detectable difference in radiological progression. J Rheumatol 2001; 28: 9113.
  • 24
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine alone in early arthritis. Lancet 1997; 350: 30918.
  • 25
    Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343: 1594602.
  • 26
    Bathon JM, Martin RW, Fleishmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000; 343: 158693.
  • 27
    Van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 1993; 20: 128896.
  • 28
    Garnero P, Landewé RB, Boers M, Christgau S, van der Linden SJ, van der Heijde D. Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic therapy (DMARD) [abstract]. Arthritis Rheum 2002; 46 Suppl 9: S376.
  • 29
    Garnero P, Landewé R, Boers M, Verhoeven A, van der Linden SJ, Christgau S, et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study. Arthritis Rheum 2002; 46: 284756.